NEKTAR THERAPEUTICS (NKTR) Operating cash flow 2016–2025
NEKTAR THERAPEUTICS (NKTR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$208.5MFY2025 · since FY2016: -$117.0M → -$208.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$208.5M | -18.7% |
| FY2024 | -$175.7M | +8.8% |
| FY2023 | -$192.6M | +36.6% |
| FY2022 | -$304.0M | +26.3% |
| FY2021 | -$412.7M | -31.7% |
| FY2020 | -$313.3M | +4.7% |
| FY2019 | -$328.7M | -145.8% |
| FY2018 | $718.2M | +993.1% |
| FY2017 | -$80.4M | +31.3% |
| FY2016 | -$117.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice